Targeted MPI market Magnetic Insight operates in the emerging magnetic particle imaging space with real time functional imaging capabilities, presenting a focused sales opportunity to early adopters in clinical research and translational medicine who require quantitative vascular and biomarker imaging.

Strategic clients Recent client win with City of Hope indicates interest from major cancer research and treatment centers; prioritize outreach to top academic medical centers and research hospitals expanding MPI capabilities.

Funding momentum Significant venture funding rounds including a $17M Series B and a $3M seed signal strong investor confidence; leverage this momentum to approach potential customers with case studies and ROI projections tied to MPI adoption.

Product roadmap Momentum CT product lineage and ongoing MPI technology development suggest opportunities to upsell or bundle with complementary imaging modalities for integrated diagnostic workflows in research and preclinical settings.

Operational scale Current headcount is modest, indicating a need for scalable partnerships, distributors, and channel programs to accelerate market reach; explore reseller agreements and clinical translation partnerships to widen dissemination.